Nanotechnology and the environment: A European perspective

The potential positive and negative effects of nanotechnology on the environment are discussed. Advances in nanotechnology may be able to provide more sensitive detection systems for air and water quality monitoring, allowing the simultaneous measurement of multiple parameters and real time response capability. Metal oxide nanocatalysts are being developed for the prevention of pollution due to industrial emissions and the photocatalytic properties of titanium dioxide nanoparticles can be exploited to create self-cleaning surfaces that reduce existing pollution. However, while nanotechnology might provide solutions for certain environmental problems, relatively little is known at present about the environmental impact of nanoparticles, though in some cases chemical composition, size and shape have been shown to contribute to toxicological effects. Nanotechnology can assist resource saving through the use of lightweight, high strength materials based on carbon nanotubes and metal oxide frameworks as hydrogen storage materials. Other energy related applications include nanostructured electrode materials for improving the performance of lithium ion batteries and nanoporous silicon and titanium dioxide in advanced photovoltaic cells. It is important to develop an efficient strategy for the recycling and recovery of nanomaterials and methods are needed to assess whether the potential benefits of nanotechnology outweigh the risks. Life cycle analysis will be a useful tool for assessing the true environmental impacts.     

Pharmacokinetics and physiologically-based pharmacokinetic modeling of nanoparticles

The worldwide commerce involving nanoparticles will soon reach $1 trillion and already we have more than 600 commercial products containing nanoparticles. Because nanoparticles are invisible and little is known about their toxicities, there has been concern about health effects in humans. As toxicology is a continuum of pharmacokinetics and pharmacodynamics, this is a review of recent advances on pharmacokinetics and physiologically-based pharmacokinetic (PBPK) modeling involving nanoparticles. We provide a synopsis of the state-of-the-science on the absorption, distribution, metabolism, and excretion (ADME) of nanoparticles in mammals, as well as some of the unique applications of pharmacokinetics to nanotechnology. Earlier, the main emphasis of pharmacokinetics of nanoparticles centered around the "control release" of drugs. Thus, drugs encapsulated by lipidic nanoparticles or bound to nano-particles form a controlled-release mechanism. The end results included, among others, enhancement of therapeutic duration and reversion of multidrug resistance. As the science advances in this area, the resulting achievements included: (1) utilizing nanoparticles as delivery vehicle for drugs, drug combinations, or genetic materials; (2) capitalizing on physico-chemical properties and tissue affinity of nanoparticles for medical imaging; (3) potentiating drug effects on immunotoxin and anticancer drugs; and (4) creating "stealth" capability from body's defense system. More recently, the application of biologically-based computer modeling to nanoparticles made it possible not only for inter-species, inter-routes, and inter-dose extrapolations but also for the integration of the modern tumor biology and computational technology for the possible improvement of cancer chemotherapy. Although pharmacokinetics and PBPK modeling of nanoparticles are still in their infancy, impressive innovations have already been demonstrated in their applications to medical sciences. Nanotoxicology is one of the most promising and fertile areas of science given the importance of nanoparticles to the economy of the 21st century, their possible environmental fates, as well as the potential health concerns of these particles.     

How to assess the risks of nanotechnology: learning from past experience

Nanotechnology may yield a plethora of beneficial applications, but it can also be expected to present risks. The challenge is to anticipate and reduce environmental and health risks or, at a minimum, identify and deal with such threats once they begin to become evident. Past experience, particularly with the fuel additive MTBE (methyl tertiary butyl ether), provides valuable guidance on how to assess the potential risks of nanotechnology using a comprehensive environmental assessment approach, which combines a product life-cycle perspective with the risk assessment paradigm. This systematic approach can serve not only to guide the development of a research strategy for assessing the risks of nanotechnology but possibly even help avert unintended consequences of nanotechnology.     

Environmental,health and safety aspects of nanotechnology—implications for the R&D in (small) companies

The growth of nanotechnology has led to an unprecedented research and development effort in both the public and the private sectors; world wide, an increasing number of laboratories, fabrication and manufacturing plants develop or apply novel nanometre-sized materials for applications ranging from large-scale industrial materials, to electronic components and healthcare and medical products; an increasing number of start-ups have been launched to establish their nanotechnology-based products in a trillion-dollar market.

Very little, however, is known about the interaction of man-made nanostructured materials and living organisms, as studies of nanotoxicology are gaining increasing interest, but are still in their infancy. Despite the formation of many focus and lobbying groups, proper legislation of the environmental, health and safety aspects of nanotechnology will take years to be implemented. In the mean time, it is of utmost importance that companies working with nanometre-sized matter take appropriate precautions to protect their staff, the environment and the customer. Toxicology tests and agency approval of new nanometre-sized materials are prohibitively expensive, but, even if working on a tight budget, nanotechnology companies can achieve an ethical and safe business conduct via a number of possible routes.     

A decision-directed approach for prioritizing research into the impact of nanomaterials on the environment and human health

The emergence of nanotechnology has coincided with an increased recognition of the need for new approaches to understand and manage the impact of emerging technologies on the environment and human health. Important elements in these new approaches include life-cycle thinking, public participation and adaptive management of the risks associated with emerging technologies and new materials. However, there is a clear need to develop a framework for linking research on the risks associated with nanotechnology to the decision-making needs of manufacturers, regulators, consumers and other stakeholder groups. Given the very high uncertainties associated with nanomaterials and their impact on the environment and human health, research resources should be directed towards creating the knowledge that is most meaningful to these groups. Here, we present a model (based on multi-criteria decision analysis and a value of information approach) for prioritizing research strategies in a way that is responsive to the recommendations of recent reports on the management of the risk and impact of nanomaterials on the environment and human health.     

Nanotechnology and nanomaterials: toxicology, risk assessment, and regulations

Nanomaterials have very unique chemical and physical properties that suggest potential health hazards, but limited health and safety information exists for engineered nanomaterials. This review identifies a need for expanding efforts for addressing health and safety concerns in nanotechnology development and in nanotoxicology of engineered nanomaterials. The efforts include research to generate data for safety evaluation, toxicologic evaluation of potential human health effects, risk assessment to support risk-management decision-making, and regulations development to protect human health and the environment. The federal government's current understanding is that existing statutory authorities are adequate to address oversight of nanotechnology and its applications. On the other hand, the present review identifies weaknesses in the current research efforts and inadequacies in existing regulations. A collaborative effort involving multidisciplinary groups is a key element to address the related needs and issues. While federal agencies with regulatory responsibilities are looked upon to develop and implement sound policies and regulations to protect public health and the environment, state agencies may be required to initiate policies which rapidly incorporate new innovations and address public concerns. To address current and futures need related to nanotechnology, the responsible state agencies need to fill the information gaps and address the health and environmental issues. In California, activities have been initiated, but legislative authority and resources are required to provide risk assessment and health protection in an efficient and timely manner.     

纳米材料在环境毒理中的作用与研究

纳米技术作为一种时代的主流技术,将人们对微观世界的认识水平及改造水平提升到了前所未有的高度,但是纳米材料也对环境产生了一定的危害。文章从环境毒理学的角度简述了纳米材料产生环境毒理学效应的途径与机制,以及纳米材料对土壤、大气和水体的毒理行为。同时,结合国内外文献报道,对目前有关纳米材料环境毒性研究方面的工作进展情况进行了总结与展望。     

Ecotoxicological effects of carbon nanomaterials on algae, fungi and plants

The ecotoxicological effects of carbon nanomateriales (CNMs), namely fullerenes and carbon nanotubes, on algae, fungi and plants are analyzed. In different toxicity tests, both direct and indirect effects were found. The direct effects are determined by nanomaterial chemical composition and surface reactivity, which might catalyze redox reactions in contact with organic molecules and affect respiratory processes. Some indirect effects of carbon nanoparticles (CNPs) are physical restraints or release of toxic ions. Accumulation of CNPs in photosynthetic organs provokes obstruction in stomata, foliar heating and alteration in physiological processes. The phytotoxicity studies of CNMs should be focused on determining phytotoxicity mechanisms, size distribution of CNPs in solution, uptake and translocation of nanoparticles by plants, on characterization of their physical and chemical properties in rhizosphere and on root surfaces. More studies on plants and algae, as a part of food chain, are needed to understand profoundly the toxicity and health risks of CNMs as ecotoxicological stressors. Correct and detailed physical and chemical characterization of CNMs is very important to establish the exposure conditions matching the realistic ones. Ecotoxicity experiments should include examinations of both short and long-term effects. One must take into account that real carbon nanomaterials are complex mixtures of carbon forms and metal residues of variable chemistry and particle size, and the toxicity reported may reflect these byproducts/residues/impurities rather than the primary material structure. One more recommendation is not only to focus on the inherent toxicity of nanoparticles, but also consider their possible interactions with existing environmental contaminants.     

A Review of the Industrial Ecology of Particulate Pharmaceuticals and Waste Minimization Approaches

The detection of pharmaceutical chemicals in the environment is viewed with concern because of their biological activity, although thus far no measurable risks to human health have been demonstrated from their presence in the environment. The particulate nature of pharmaceutical chemicals, especially solid and semisolid dosage forms, has received considerable attention from the point of view of raw material and finished product quality, but little attention from the point of view of their ecosystem effects. Therefore, research in support of the interaction of particulate pharmaceuticals and environmental matrices is much needed. The current state of understanding on this subject is summarized in this review with discussions on life cycle of pharmaceutical drugs, pharmaceutical supply chain management activities on waste minimization, and potential environmental exposure during manufacture, use, and disposal. The distribution, dilution, and degradation in various environmental matrices are explained and illustrated in flowcharts.     

Nanomaterials patenting in Brazil: some considerations for the national regulatory framework

Progress on the development of nanotechnology has led to a number of initiatives which serve to normalize activities in this area. Among emerging technologies, nanotechnology is one of the most prominent, and it raises high expectations in a wide range of areas affecting daily life. The risks to human health, the pathways of exposure to nanomaterials, and occupational safety are recent issues which require more attention. The study was performed on nanopatents by collecting, processing and analyzing information extracted from specialized patent databases covering the period from 1991 to 2011, totalling 1,343 patents and representing 36 countries. These patents were classified by the International Patent Classification, using the methodology proposed in a study published by Organization for Economic Co-operation and Development, which resulted in six groups of patents, distributed as follows: nanomaterials (40.3 %), medicine and biotechnology (26.6 %), measurement and production (10 %), electronics (2.7 %), energy and the environment (2.2 %), and optical electronics (1 %). Around 17 % of the patents in question did not fall into the adopted classification. The aim of this paper is to analyze the main trends of patenting related to nanotechnology, its development and environmental implications. An additional goal is to assist policy-makers to adjust the regulatory framework on nanotechnology, and to make recommendations for governments, industry, and national organizations, on creating specific subsidies for regulatory framework in Brazil.     

Effects of diamond nanoparticle exposure on the internal structure and reproduction of Daphnia magna

Nanomaterials have significant technological advantages but their release into the environment also carry potential ecotoxicological risks. Carbon-based nanoparticles and particularly diamond nanoparticles have numerous industrial and medical applications. The aim of the present study was to evaluate the toxic effects of diamond nanoparticles with an average particle size of 20 nm on the survival, reproduction and tissue structure of the freshwater crustacean Daphnia magna. The chronic toxicity test results showed 100% mortality at concentrations higher than 12.5 mg l(-1) and that reproduction inhibition occurred in concentrations higher than 1.3 mg l(-1). Light microscopy showed that diamond nanoparticles adhere to the exoskeleton surface and accumulate within the gastrointestinal tract, suggesting that food absorption by the gut cells may be blocked. The results support the use of chronic approaches in environmental protection as part of an integrated environmental monitoring and assessment strategy.     

Application of nanotechnology to control bacterial adhesion and patterning on material surfaces

Bacterial adhesion and biofilm formation on surfaces raises health hazard issues in the medical environment. Previous studies of bacteria adhesion have focused on observations in their natural/native environments. Recently, surface science has contributed in advancing the understanding of bacterial adhesion by providing ideal platforms that attempt to mimic the bacteria's natural environments, whilst also enabling concurrent control, selectivity and spatial control of bacterial adhesion. In this review, we will look at techniques of how nanotechnology is used to control cell adhesion on a planar scale, in addition to describing the use of nanotools for cell micropatterning. Additionally, it will provide a general background of common methods for nanoscale modification enabling biologist unfamiliar with nanotechnology to enter the field.     

In vitro cytotoxicity of transparent yellow iron oxide nanoparticles on human glioma cells

With rapid development of nanotechnology, concerns about the possible adverse health effects on human beings by using nanomaterials have been raised. Transparent yellow iron oxide (alpha-FeOOH) nanoparticles have been widely used in paints, plastic, rubber, building materials, papermaking, food products and pharmaceutical industry, thus the potential health implications by the exposure should be considered. The purpose of this study is to assess the cytotoxicity of transparent yellow iron oxide nanoparticles on U251 human glioma cells. The alpha-FeOOH nanoparticles are in clubbed shapes with 9 nm in diameter and 43 nm long. The specific surface area is 115.3 m2/g. After physicochemical characterization of the nanoparticles, U251 cells were exposed to a-FeOOH at the doses of 0, 3.75, 15, 60 and 120 microg/mL. The results showed that the alpha-FeOOH nanoparticles reduced the cell viability and induced necrosis and apoptosis in U251 cells. In addition, nanoparticle exposure significantly increased the levels of superoxide anion and nitric oxide in a dose-dependent fashion in the cells. Our results suggest that exposure to alpha-FeOOH nanoparticles induce significant free radical formation and cytotoxic effects. The large surface area that induced high surface reactivity may play an important role in the cytotoxic effect of alpha-FeOOH nanoparticles.     

Dealing with uncertainty and pursuing superior technology options in risk management--the inherency risk analysis

Current regulatory systems focus on the state of scientific evidence as the predominant factor for how to handle risks to human health and the environment. However, production and assessment of risk information are costly and time-consuming, and firms have an intrinsic disincentive to produce and distribute information about risks of their products as this could endanger their production opportunities and sales. An emphasis on more or better science may result in insufficient thought and attention going into the exploration of technology alternatives, and that risk management policies miss out on the possible achievement of a more favorable set of consequences. In this article, a method is proposed that combines risk assessment with the search for alternative technological options as a part of the risk management procedure. The method proposed is the inherency risk analysis where the first stage focuses on the original agent subject to investigation, the second stage focuses on identifying technological options whereas the third stage reviews the different alternatives, searching for the most attractive tradeoffs between costs and inherent safety. This is then used as a fundament for deciding which technology option to pursue. This method aims at providing a solution-focused, systematic technology-based approach for addressing and setting priorities for environmental problems. By combining risk assessment with a structured approach to identify superior technology options within a risk management system, the result could very well be a win-win situation for both company and the environment.     

In Vivo toxicity assessment of gold nanoparticles in Drosophila melanogaster

The growing use of nanomaterials in commercial goods and novel technologies is generating increasing questions about possible risks for human health and environment, due to the lack of an in-depth assessment of their potential toxicity. In this context, we investigated the effects of citrate-capped gold nanoparticles (AuNPs) on the model system Drosophila melanogaster upon ingestion. We observed a significant in vivo toxicity of AuNPs, which elicited clear adverse effects in treated organisms, such as a strong reduction of their life span and fertility, presence of DNA fragmentation, as well as a significant overexpression of the stress proteins. Transmission electron microscopy demonstrated the localization of the nanoparticles in tissues of Drosophila. The experimental evidence of high in vivo toxicity of a nanoscale material, which is widely considered to be safe and biocompatible in its bulk form, opens up important questions in many fields, including nanomedicine, material science, health, drug delivery and risk assessment.      

Implications of the space radiation environment for human exploration in deep space

Human exploration of the solar system beyond Earth's orbit will entail many risks for the crew on these deep space missions. One of the most significant health risks is exposure to the harsh space radiation environment beyond the protection provided by the Earth's intrinsic magnetic field. Crew on exploration missions will be exposed to a complex mixture of very energetic particles. Chronic exposures to the ever-present background galactic cosmic ray (GCR) spectrum consisting of all naturally occurring chemical elements are combined with sporadic, possibly acute exposures to large fluxes of solar energetic particles, mainly protons and alpha particles. The background GCR environment is mainly a matter of concern for stochastic effects, such as the induction of cancer with subsequent mortality in many cases, and late deterministic effects, such as cataracts and possible damage to the central nervous system. Unfortunately, the actual risks of cancer induction and mortality owing to the very important high-energy heavy ion component of the GCR spectrum are essentially unknown. The sporadic occurrence of extremely large solar energetic particle events (SPE), usually associated with intense solar activity, is also a major concern for the possible manifestation of acute effects from the accompanying high doses of such radiations, especially acute radiation syndrome effects such as nausea, emesis, haemorrhaging or, possibly, even death. In this presentation, an overview of the space radiation environment, estimates of the associated body organ doses and equivalent doses and the potential biological effects on crew in deep space are presented. Possible methods of mitigating these radiations, thereby reducing the associated risks to crew are also described.     

Health-health analysis-an alternative method for economic appraisal of health policy and safety regulation. Some empirical Swedish estimates

Health-health analysis (HHA) focuses on statistical lives themselves as a numeraire. The underlying principle is that the expected gains in health and safety of reduced risks in one area may result in increasing risks somewhere else in society. By reducing one risk other risks may increase due to changed individual behaviour.In addition to this direct effect, another indirect effect will also be present. Expenditure on a particular health policy or safety regulation must be financed in one way or another, which will result in an opportunity cost or income effect leaving less resources for other health and safety promoting activities in society. Thus, we will have an effect that reduces safety and health benefits induced by that income loss. Whether the total net health effect from a specific safety regulation or health policy is positive or negative must be empirically analysed. One way of estimating the income loss that induces one death, which we call the value of an induced death (VOID), is to estimate it as a multiple of the traditional value to avert a statistical death, also named the value of a statistical life (VOSL).A contingent valuation (CV) study eliciting the willingness-to-pay (WTP) for reducing the overall risk of dying was performed as a postal questionnaire in Sweden in 1998. By use of data from this study, it was possible to estimate the VOID and the VOSL in Sweden amounting to SEK116 and SEK20.8 million respectively, indicating that the net health result confined to mortality effects, will be negative (more lives will be lost than saved) if a health policy or safety regulation will cost more than SEK116 million per life saved.     

Safety,health or the environment--which comes first?

This paper describes the development and application of two integrated models which can be used for assessing the life cycle risk (to life) and environmental impact of a number of possible concept options for new offshore oil and gas developments. The two models can also be used for ranking the designs in terms of lowest human risk and environmental impact. The paper also gives values/criteria for both risks to safety, health and the environment by which the total safety, health and environmental assessment/impact may be balanced as a whole. The paper illustrates the use of the models and shows that the pragmatic or cosmetic improvement to safety, health or the environment may not be advantageous to the overall safety, health and environmental objectives. While the models were developed originally for offshore installations, the basic framework can be readily adapted for use on onshore petrochemical processes.     

The role of cobalt ferrite magnetic nanoparticles in medical science

The nanotechnology industry is rapidly growing and promises that the substantial changes that will have significant economic and scientific impacts be applicable to a wide range of areas, such as aerospace engineering, nano-electronics, environmental remediation and medical healthcare. In this area, cobalt ferrite nanoparticles have been regarded as one of the competitive candidates because of their suitable physical, chemical and magnetic properties like the high anisotropy constant, high coercivity and high Curie temperature, moderate saturation magnetization and ease of synthesis. This paper introduces the magnetic properties, synthesis methods and some medical applications, including the hyperthermia, magnetic resonance imaging (MRI), magnetic separation and drug delivery of cobalt ferrite nanoparticles.     

我国纳米材料技术应用的现状和产业化的机遇

概述了我国纳米材料应用的现状及应用纳米技术对传统产业,环境,能源,医药和信息领域等产品升级带来新的机遇,提出了发展我国纳米产业的指导思想和目标,并对“十五”期间我国应重点发展的纳米产业进行了评述。